AMEX:PLX

An Analysis of Protalix BioTherapeutics Inc (PLX)’s Potential Price Growth
Anna Perez
Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...

Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...